I think what might happen is the other company that is part of this non-binding agreement will PR the news, their followers will ask "who is this Cytodyn?" and then see what Leronlimab is and say "holy crap! this drug is amazing!" and then our SP will be on the radar of a huge number of investors of all types that had no idea this drug even existed.